ATH
Click for more information
0.00% 0.5¢ alterity therapeutics limited

With half amount of Market Cap in hand, they do not have any...

  1. lwlinwei
    405 Posts.
    lightbulb Created with Sketch. 38
    clock Created with Sketch.
    02/09/21
    00:08
    Post #: 55765504
    With half amount of Market Cap in hand, they do not have any excuse to delay the P2 study. Unless, they found something important that might lead to a higher possibility of P2 success. If it is the case, it is worthy to wait and be patient.
    ATH Price at posting: 3.2¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $8.75K 1.75M

Buyers (Bids)

No. Vol. Price($)
59 63306661 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28430837 21
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.